Stevanato Group to Present at Upcoming Investor Conference
September 09 2022 - 9:00AM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment, drug delivery, and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries,
announced today that management will present at the Bank of America
Global Healthcare Conference in London at 9:05 a.m. (BST) on
September 15, 2022.
A webcast will be available on the investor section of the
Company’s website, www.stevanatogroup.com, under the “News &
Events” tab.
About Stevanato Group Founded in 1949, Stevanato Group is
a leading global provider of drug containment, drug delivery and
diagnostic solutions to the pharmaceutical, biotechnology, and life
sciences industries. The Group delivers an integrated, end-to-end
portfolio of products, processes and services that address customer
needs across the entire drug life cycle at each of the development,
clinical and commercial stages. Stevanato Group’s core capabilities
in scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients.
For more information, please visit www.stevanatogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220909005255/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Stevanato (NYSE:STVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Stevanato (NYSE:STVN)
Historical Stock Chart
From Apr 2023 to Apr 2024